GB1556567A - Pharmaceutical compositions having an action on the central nervous system - Google Patents

Pharmaceutical compositions having an action on the central nervous system

Info

Publication number
GB1556567A
GB1556567A GB30355/77A GB3035577A GB1556567A GB 1556567 A GB1556567 A GB 1556567A GB 30355/77 A GB30355/77 A GB 30355/77A GB 3035577 A GB3035577 A GB 3035577A GB 1556567 A GB1556567 A GB 1556567A
Authority
GB
United Kingdom
Prior art keywords
action
pharmaceutical compositions
nervous system
central nervous
central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30355/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7622045A external-priority patent/FR2358881A1/en
Priority claimed from FR7719390A external-priority patent/FR2453643A2/en
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of GB1556567A publication Critical patent/GB1556567A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
GB30355/77A 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system Expired GB1556567A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (en) 1976-07-20 1976-07-20 Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia
FR7719390A FR2453643A2 (en) 1977-06-24 1977-06-24 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Publications (1)

Publication Number Publication Date
GB1556567A true GB1556567A (en) 1979-11-28

Family

ID=26219550

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30355/77A Expired GB1556567A (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system

Country Status (11)

Country Link
JP (1) JPS5326327A (en)
AU (1) AU508753B2 (en)
CA (1) CA1077846A (en)
DE (1) DE2732614A1 (en)
GB (1) GB1556567A (en)
IE (1) IE45454B1 (en)
IL (1) IL52550A (en)
LU (1) LU77796A1 (en)
NL (1) NL7708055A (en)
NZ (1) NZ184666A (en)
SE (1) SE7708349L (en)

Also Published As

Publication number Publication date
NZ184666A (en) 1980-04-28
DE2732614A1 (en) 1978-01-26
LU77796A1 (en) 1977-10-25
SE7708349L (en) 1978-01-21
AU2715177A (en) 1979-01-25
NL7708055A (en) 1978-01-24
IL52550A0 (en) 1977-10-31
JPS5326327A (en) 1978-03-11
IL52550A (en) 1981-03-31
CA1077846A (en) 1980-05-20
IE45454B1 (en) 1982-08-25
IE45454L (en) 1978-01-20
AU508753B2 (en) 1980-04-03

Similar Documents

Publication Publication Date Title
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
JPS52125619A (en) Pharmaceutical vehicle
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
PT66622A (en) Pharmaceutical compositions
GB2003467B (en) 2,4-benzodiazepines
ZA777711B (en) Hydrogenation
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
AU2609277A (en) Pharmaceutical compositions
IL48624A0 (en) 2,3-dihydroergolines
GB1557694A (en) 2,9 dichlorquinacridone
PH14168A (en) 2,4-pyrrolidinediones
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1522923A (en) 1,4 - benzodiazepines
GB1547206A (en) Pharmaceutical compositions
PT66509A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
GB1554021A (en) 4,5-didehydroprostaglandins
ZA774376B (en) Pharmaceutical compositions having an action on the central nervous system
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition
HK3984A (en) Pharmaceutical compositions
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
GB1554925A (en) 2,3-methyl-eneprostaglandins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee